1. Home
  2. ARAY vs CCEL Comparison

ARAY vs CCEL Comparison

Compare ARAY & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.25

Market Cap

31.3M

Sector

Health Care

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$4.40

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAY
CCEL
Founded
1990
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
30.9M
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
ARAY
CCEL
Price
$0.25
$4.40
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$3.50
N/A
AVG Volume (30 Days)
497.6K
14.2K
Earning Date
05-06-2026
04-14-2026
Dividend Yield
N/A
4.26%
EPS Growth
87.50
N/A
EPS
N/A
0.07
Revenue
N/A
$25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.58
N/A
P/E Ratio
N/A
$62.86
Revenue Growth
N/A
9.76
52 Week Low
$0.22
$2.72
52 Week High
$2.10
$5.01

Technical Indicators

Market Signals
Indicator
ARAY
CCEL
Relative Strength Index (RSI) 40.39 52.90
Support Level $0.23 $3.04
Resistance Level $0.33 $4.38
Average True Range (ATR) 0.02 0.25
MACD -0.00 -0.02
Stochastic Oscillator 12.33 25.00

Price Performance

Historical Comparison
ARAY
CCEL

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: